Cardiovascular Syst (CSII) 24.69 $CSII Cardiova
Post# of 273319
Posted On: 09/02/2016 11:17:31 PM
Cardiovascular Syst (CSII) 24.69 $CSII
Cardiovascular Systems Launches the Take A Stand Against Amputation Program in Time for September Peripheral Artery Disease (PAD) Awareness Month
BusinessWire - Thu Sep 01, 7:00AM CDT
September marks Peripheral Artery Disease (PAD) Awareness Month. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), has launched a public awareness and patient advocacy program, Take A Stand Against Amputation, to provide education about the disease and treatment options.
CSII: 24.69 (+0.24)
Cardiovascular Systems (CSII) Catches Eye: Stock Up 5.6%
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 7:40AM CDT
Cardiovascular Systems Inc. (CSII) saw its shares almost 6% in the last trading session.
CSII: 24.69 (+0.24), GWPH: 82.73 (+0.45)
Cardiovascular Systems Names Scott Ward as CEO
BusinessWire - Tue Aug 16, 6:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), today announced that, following a national search, it has named Scott R. Ward, 56, the company's new Chairman and Chief Executive Officer, effective immediately. Ward has been serving as Chairman since November 2014 and Interim President and Chief Executive Officer since November 2015. He joined CSI's board in 2013. Edward Brown, a member of CSI's board since 2009, has been appointed as CSI's Lead Independent Director.
CSII: 24.69 (+0.24)
Cardiovascular Systems Releases 30-Day Results from Liberty 360° Study in Late-Breaking Presentation at 2016 Amputation Prevention Symposium
BusinessWire - Thu Aug 11, 9:30AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), today released procedural and 30-day results from its LIBERTY 360° study in a late-breaking presentation at the 2016 Amputation Prevention Symposium (AMP) in Chicago.
CSII: 24.69 (+0.24)
Cardiovascular Systems (CSII) Loss Narrows Y/Y in Q4
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:58AM CDT
Cardiovascular Systems' (CSII) fiscal fourth-quarter loss was narrower than the Zacks Consensus Estimate; the top line also comfortably surpassed the mark.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), CSII: 24.69 (+0.24), IDXX: 114.09 (+0.93)
Upgrade Alert for Cardiovascular Systems (CSII)
Comtex SmarTrend(R) - Fri Aug 05, 3:01AM CDT
Cardiovascular Systems (NASDAQ:CSII) was upgraded from Underperform to Neutral at BofA/Merrill today. The stock closed yesterday at $21.23 on volume of 1.2 million shares, above average daily volume of 344,000. Cardiovascular Systems (NASDAQ:CSII) defies analysts with a current price ($21.23) 8.3% above its average consensus price target of $19.46. Cardiovascular Systems shares have support at the 200-day moving average (MA) of $15.61 and additional support at the 50-day MA of $11.78.
CSII: 24.69 (+0.24)
Cardiovascular Systems Reports Fiscal 2016 Fourth-Quarter Financial Results
BusinessWire - Wed Aug 03, 3:16PM CDT
--Revenues of $48.5 million grew 9% from third quarter of fiscal 2016, and were similar to the prior year Coronary device revenues grew 20% from prior year
CSII: 24.69 (+0.24)
Medical Product Stocks Earnings Preview for Aug 3: BIO, CSII & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:35AM CDT
Medical has been a stand out performer so far in Q2.
MGNX: 29.64 (-0.41), INSY: 14.63 (+0.27), CSII: 24.69 (+0.24), BIO: 151.14 (+1.65), CNAT: 1.84 (-0.02)
Cardiovascular Systems Up 88.6% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri Jul 29, 12:13AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 5 months, Cardiovascular Systems has returned 88.61% as of today's recent price of $19.30.
CSII: 24.69 (+0.24)
Cardiovascular Systems Has Returned 66.0% Since SmarTrend Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 21, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 65.98% as of today's recent price of $16.98.
CSII: 24.69 (+0.24)
Cardiovascular Systems Shares Up 78.3% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 14, 12:12AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 78.30% as of today's recent price of $18.24.
CSII: 24.69 (+0.24)
FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility
PR Newswire - Fri Jun 10, 10:30AM CDT
Terumo Cardiovascular Systems (Terumo CVS) received notice from the U.S. Food and Drug Administration (FDA) that it has successfully completed the second and final phase of its work plan to remediate all products manufactured or distributed from Terumo's Ann Arbor, Michigan manufacturing facility, including Terumo® Advanced Perfusion System 1. As a result, all shipping restrictions, imposed as a term of its 2011 consent decree, are now lifted.
CSII: 24.69 (+0.24)
Cardiovascular Systems Up 70.3% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri May 27, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 70.28% as of today's recent price of $17.42.
CSII: 24.69 (+0.24)
44.0% Return Seen to Date on SmarTrend Cardiovascular Systems Call (CSII)
Comtex SmarTrend(R) - Fri May 20, 12:34AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 43.99% as of today's recent price of $14.73.
CSII: 24.69 (+0.24)
Cardiovascular Systems Shares Up 42.4% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Thu May 12, 1:03PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 42.42% as of today's recent price of $14.57.
CSII: 24.69 (+0.24)
Updated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc.
PR Newswire - Thu May 12, 12:07PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Cardiovascular Systems, Inc. ("CSII" or the "Company"
(NASDAQ: CSII), concerning whether the board has breached its fiduciary duties to shareholders.
CSII: 24.69 (+0.24)
Cardiovascular (CSII) Narrows Loss in Q3, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:36AM CDT
Cardiovascular Systems Inc. (CSII) reported third-quarter fiscal 2016 adjusted net loss per share of 31 cents.
CAPR: 3.80 (+0.16), CSII: 24.69 (+0.24), BAX: 46.28 (+0.10), CRDC: 2.35 (-0.15)
Cardiovascular Systems Shares Final Three-Year ORBIT II Results at 2016 Society for Cardiovascular Angiography and Interventions Annual Meeting
BusinessWire - Thu May 05, 7:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Florida.
CSII: 24.69 (+0.24)
Shares of CSII Up 33.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 05, 12:54AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 33.63% as of today's recent price of $13.67.
CSII: 24.69 (+0.24)
Cardiovascular Systems Launches the Take A Stand Against Amputation Program in Time for September Peripheral Artery Disease (PAD) Awareness Month
BusinessWire - Thu Sep 01, 7:00AM CDT
September marks Peripheral Artery Disease (PAD) Awareness Month. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), has launched a public awareness and patient advocacy program, Take A Stand Against Amputation, to provide education about the disease and treatment options.
CSII: 24.69 (+0.24)
Cardiovascular Systems (CSII) Catches Eye: Stock Up 5.6%
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 7:40AM CDT
Cardiovascular Systems Inc. (CSII) saw its shares almost 6% in the last trading session.
CSII: 24.69 (+0.24), GWPH: 82.73 (+0.45)
Cardiovascular Systems Names Scott Ward as CEO
BusinessWire - Tue Aug 16, 6:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), today announced that, following a national search, it has named Scott R. Ward, 56, the company's new Chairman and Chief Executive Officer, effective immediately. Ward has been serving as Chairman since November 2014 and Interim President and Chief Executive Officer since November 2015. He joined CSI's board in 2013. Edward Brown, a member of CSI's board since 2009, has been appointed as CSI's Lead Independent Director.
CSII: 24.69 (+0.24)
Cardiovascular Systems Releases 30-Day Results from Liberty 360° Study in Late-Breaking Presentation at 2016 Amputation Prevention Symposium
BusinessWire - Thu Aug 11, 9:30AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), today released procedural and 30-day results from its LIBERTY 360° study in a late-breaking presentation at the 2016 Amputation Prevention Symposium (AMP) in Chicago.
CSII: 24.69 (+0.24)
Cardiovascular Systems (CSII) Loss Narrows Y/Y in Q4
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:58AM CDT
Cardiovascular Systems' (CSII) fiscal fourth-quarter loss was narrower than the Zacks Consensus Estimate; the top line also comfortably surpassed the mark.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), CSII: 24.69 (+0.24), IDXX: 114.09 (+0.93)
Upgrade Alert for Cardiovascular Systems (CSII)
Comtex SmarTrend(R) - Fri Aug 05, 3:01AM CDT
Cardiovascular Systems (NASDAQ:CSII) was upgraded from Underperform to Neutral at BofA/Merrill today. The stock closed yesterday at $21.23 on volume of 1.2 million shares, above average daily volume of 344,000. Cardiovascular Systems (NASDAQ:CSII) defies analysts with a current price ($21.23) 8.3% above its average consensus price target of $19.46. Cardiovascular Systems shares have support at the 200-day moving average (MA) of $15.61 and additional support at the 50-day MA of $11.78.
CSII: 24.69 (+0.24)
Cardiovascular Systems Reports Fiscal 2016 Fourth-Quarter Financial Results
BusinessWire - Wed Aug 03, 3:16PM CDT
--Revenues of $48.5 million grew 9% from third quarter of fiscal 2016, and were similar to the prior year Coronary device revenues grew 20% from prior year
CSII: 24.69 (+0.24)
Medical Product Stocks Earnings Preview for Aug 3: BIO, CSII & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:35AM CDT
Medical has been a stand out performer so far in Q2.
MGNX: 29.64 (-0.41), INSY: 14.63 (+0.27), CSII: 24.69 (+0.24), BIO: 151.14 (+1.65), CNAT: 1.84 (-0.02)
Cardiovascular Systems Up 88.6% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri Jul 29, 12:13AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 5 months, Cardiovascular Systems has returned 88.61% as of today's recent price of $19.30.
CSII: 24.69 (+0.24)
Cardiovascular Systems Has Returned 66.0% Since SmarTrend Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 21, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 65.98% as of today's recent price of $16.98.
CSII: 24.69 (+0.24)
Cardiovascular Systems Shares Up 78.3% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 14, 12:12AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 78.30% as of today's recent price of $18.24.
CSII: 24.69 (+0.24)
FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility
PR Newswire - Fri Jun 10, 10:30AM CDT
Terumo Cardiovascular Systems (Terumo CVS) received notice from the U.S. Food and Drug Administration (FDA) that it has successfully completed the second and final phase of its work plan to remediate all products manufactured or distributed from Terumo's Ann Arbor, Michigan manufacturing facility, including Terumo® Advanced Perfusion System 1. As a result, all shipping restrictions, imposed as a term of its 2011 consent decree, are now lifted.
CSII: 24.69 (+0.24)
Cardiovascular Systems Up 70.3% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri May 27, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 70.28% as of today's recent price of $17.42.
CSII: 24.69 (+0.24)
44.0% Return Seen to Date on SmarTrend Cardiovascular Systems Call (CSII)
Comtex SmarTrend(R) - Fri May 20, 12:34AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 43.99% as of today's recent price of $14.73.
CSII: 24.69 (+0.24)
Cardiovascular Systems Shares Up 42.4% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Thu May 12, 1:03PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 42.42% as of today's recent price of $14.57.
CSII: 24.69 (+0.24)
Updated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc.
PR Newswire - Thu May 12, 12:07PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Cardiovascular Systems, Inc. ("CSII" or the "Company"
(NASDAQ: CSII), concerning whether the board has breached its fiduciary duties to shareholders. CSII: 24.69 (+0.24)
Cardiovascular (CSII) Narrows Loss in Q3, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:36AM CDT
Cardiovascular Systems Inc. (CSII) reported third-quarter fiscal 2016 adjusted net loss per share of 31 cents.
CAPR: 3.80 (+0.16), CSII: 24.69 (+0.24), BAX: 46.28 (+0.10), CRDC: 2.35 (-0.15)
Cardiovascular Systems Shares Final Three-Year ORBIT II Results at 2016 Society for Cardiovascular Angiography and Interventions Annual Meeting
BusinessWire - Thu May 05, 7:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Florida.
CSII: 24.69 (+0.24)
Shares of CSII Up 33.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 05, 12:54AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 33.63% as of today's recent price of $13.67.
CSII: 24.69 (+0.24)
(0)
(0)